Colgate-Palmolive (NYSE:CL) Earning Somewhat Positive Media Coverage, Report Shows

News coverage about Colgate-Palmolive (NYSE:CL) has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Colgate-Palmolive earned a news impact score of 0.22 on Accern’s scale. Accern also gave press coverage about the company an impact score of 47.655282743417 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the news stories that may have effected Accern Sentiment’s scoring:

How to Become a New Pot Stock Millionaire

NYSE CL traded down $0.24 during trading on Tuesday, hitting $72.20. 2,006,674 shares of the stock traded hands, compared to its average volume of 3,927,118. The stock has a market capitalization of $62,673.39, a PE ratio of 25.16, a P/E/G ratio of 2.70 and a beta of 0.74. The company has a debt-to-equity ratio of 27.02, a current ratio of 1.36 and a quick ratio of 1.00. Colgate-Palmolive has a 12-month low of $67.86 and a 12-month high of $77.91.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the consensus estimate of $0.75. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.75 EPS. analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be paid a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 2.33%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 55.75%.

A number of research firms have weighed in on CL. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Friday, April 6th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a report on Tuesday, December 19th. Jefferies Group reissued a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Friday, January 26th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Finally, Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $77.76.

In related news, Vice Chairman Franck J. Moison sold 142,979 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $70.09, for a total transaction of $10,021,398.11. Following the completion of the sale, the insider now directly owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Daniel B. Marsili sold 5,692 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $70.19, for a total value of $399,521.48. Following the sale, the insider now directly owns 41,677 shares of the company’s stock, valued at $2,925,308.63. The disclosure for this sale can be found here. Insiders sold a total of 454,805 shares of company stock valued at $32,375,038 over the last ninety days. Corporate insiders own 1.02% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.

Leave a Reply